Biphasic Lipid Vesicles (Biphasix™) Enhance the Adjuvanticity of CpG Oligonucleotides Following Systemic and Mucosal Administration

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|1|1|9-15

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.1, Iss.1, 2004-01, pp. : 9-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biphasic Lipid Vesicles as a Subcutaneous Delivery System for Protein Antigens and CpG Oligonucleotides

By  

Current Drug Delivery, Vol. 3, Iss. 2, 2006-04 ,pp. : 129-135

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Delivery into Human Skin In Vitro Using Biphasic Lipid Vesicles

By  

Current Drug Delivery, Vol. 3, Iss. 1, 2006-01 ,pp. : 89-93

Bentham Science Publishers

Access to resources Recommend Favorite

Intramammary Application of Non-Methylated-CpG Oligodeoxynucleotides (CpG) Inhibits both Local and Systemic Mammary Carcinogenesis in Female BALB/c Her-2/neu Transgenic Mice

By  

Current Cancer Drug Targets, Vol. 8, Iss. 3, 2008-05 ,pp. : 230-242

Bentham Science Publishers

Access to resources Recommend Favorite

CpG 7909: PF 3512676, PF-3512676

By Adis International Limited  

Drugs in R&D, Vol. 7, Iss. 5, 2006-01 ,pp. : 312-316

Adis International

Access to resources Recommend Favorite

Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species

By Manuja Anju   Manuja Balvinder K.   Kaushik Jyoti   Singha Harisankar   Singh Raj Kumar  

Immunopharmacology and Immunotoxicology, Vol. 35, Iss. 5, 2013-10 ,pp. : 535-544

Informa Healthcare

Access to resources Recommend Favorite